Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.1K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.1K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

99
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Breast Parenchymal Enhancement to Predict Breast Cancer Recurrence.

Radiology·2024
Same author

Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.

Radiology·2020
Same author

Deep learning detection of prostate cancer recurrence with <sup>18</sup>F-FACBC (fluciclovine, Axumin®) positron emission tomography.

European journal of nuclear medicine and molecular imaging·2020
Same author

Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment.

The breast journal·2020
Same author

Identifying tests related to breast cancer care in claims data.

The breast journal·2019

Related Experiment Video

Updated: Jun 17, 2025

Imaging of Estrogen Receptor-&#945; in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
07:42

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope

Published on: November 29, 2011

12.4K

Estrogen Receptor-targeted PET Imaging for Breast Cancer.

Wenhui Zhou1, Benjamin L Franc1, Wendy B DeMartini1

  • 1From the Department of Radiology, Stanford University Medical Center, 300 Pasteur Dr, H1MD330, MC 5621, Stanford, CA 94305.

Radiology
|August 13, 2024
PubMed
Summary

Estrogen receptor (ER)-targeting imaging, using fluorine 18 fluoroestradiol PET, is crucial for planning and selecting endocrine therapy in breast cancer patients. This approach aids in personalized treatment strategies for improved patient outcomes.

More Related Videos

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.8K
Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

6.1K

Related Experiment Videos

Last Updated: Jun 17, 2025

Imaging of Estrogen Receptor-&#945; in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
07:42

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope

Published on: November 29, 2011

12.4K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.8K
Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

6.1K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Estrogen receptor (ER) status is a key determinant in selecting endocrine therapy for breast cancer.
  • Accurate assessment of ER expression is vital for effective treatment planning.
  • Current methods for assessing ER status may have limitations in certain clinical scenarios.

Purpose of the Study:

  • To highlight the clinical utility of estrogen receptor (ER)-targeting imaging in breast cancer treatment planning.
  • To demonstrate the importance of ER-targeting imaging for selecting appropriate endocrine therapy.
  • To discuss the role of fluorine 18 fluoroestradiol Positron Emission Tomography (PET) in evaluating ER-positive breast cancer.

Main Methods:

  • Presentation of two complementary patient cases.
  • Discussion of radiopharmaceuticals and underlying biology of ER-targeting agents.
  • Review of imaging interpretation principles for ER-targeting PET scans.
  • Analysis of current clinical applications and evidence supporting ER-PET imaging.

Main Results:

  • ER-targeting imaging provides valuable information for treatment decisions beyond conventional methods.
  • Fluorine 18 fluoroestradiol PET can accurately assess ER expression in vivo.
  • Case examples illustrate how ER-PET influences therapeutic strategy and patient management.

Conclusions:

  • ER-targeting imaging, particularly with fluorine 18 fluoroestradiol PET, is essential for optimizing endocrine therapy selection in breast cancer.
  • This imaging modality enhances personalized medicine by providing functional assessment of ER status.
  • Further integration of ER-PET into clinical practice can improve treatment efficacy and patient outcomes.